including FDA Warning Letters, Untitled Letters, Cyber Letters and OHRP Determination Letters dating back over 30 years
Start your free trial ›
Our FDA Enforcement Manual offers the critical information you need
Learn more ›
Our Guide to Good Clinical Practice is your one-stop resource for clinical trial regulations, guidelines and best practices
"I just watched one of your webinars and thought it was great. The instructor covered a wide range of topics but did so in a very focused manner"
- Grants Administrator
"This is what I want in a resource. With the sweeping changes, I need to keep up."
- Finance and Grants Coordinator
"I’ve been working on renegotiating our indirect cost rate and my online subscription has proved very helpful in getting me up to speed. Thanks!"
- Director, Sponsored Projects Administration
Legislation Would Establish Risk-Based Scheduling of FDA’s Medical Device Establishment Inspections
Alleged Disease Claims, Labeling and cGMP Violations Lead to Shutdown of Dietary Supplement Maker
W. Va. Delegates Introduce Bill Requiring Universities To Conduct Research if Asked
Texas Bill Allows Patients To Access Investigational Stem Cell Treatments
ERSP Finds Firm Can Support Supplement Claims After Voluntarily Discontinuing Other Claims
FDA May Soon Have To Confront the Public Release of Clinical Study Reports
Fill in your information and a member of our team will be in touch shortly.